Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cosciens Biopharma Inc (CSCI)

Cosciens Biopharma Inc (CSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,041
  • Shares Outstanding, K 3,141
  • Annual Sales, $ 9,590 K
  • Annual Income, $ -15,310 K
  • EBIT $ -15 M
  • EBITDA $ -15 M
  • 60-Month Beta 1.27
  • Price/Sales 1.05
  • Price/Cash Flow N/A
  • Price/Book 0.90

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.30 +40.00%
on 04/08/25
3.30 -2.42%
on 03/26/25
+0.15 (+4.98%)
since 03/25/25
3-Month
1.96 +64.29%
on 03/13/25
4.61 -30.08%
on 03/19/25
+0.33 (+11.42%)
since 01/24/25
52-Week
1.96 +64.29%
on 03/13/25
11.10 -70.99%
on 05/29/24
-4.62 (-58.93%)
since 04/25/24

Most Recent Stories

More News
COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer

CSCI.TO : 4.45 (unch)
CSCI : 3.22 (+2.22%)
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update

CSCI.TO : 4.45 (unch)
CSCI : 3.22 (+2.22%)
COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order

CSCI.TO : 4.45 (unch)
CSCI : 3.22 (+2.22%)
COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting Documents

Toronto, Ontario--(Newsfile Corp. - March 19, 2025) - COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) ("COSCIENS" or the "Company"), a life science company which develops and commercializes a diversified...

CSCI.TO : 4.45 (unch)
CSCI : 3.22 (+2.22%)
COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting Documents

CSCI.TO : 4.45 (unch)
CSCI : 3.22 (+2.22%)
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.

TNYA : 0.4912 (+6.64%)
CSCI : 3.22 (+2.22%)
MLYS : 13.34 (-5.32%)
SWTX : 44.72 (-0.47%)
MGX : 1.7400 (-0.57%)
COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product

CSCI.TO : 4.45 (unch)
CSCI : 3.22 (+2.22%)
COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization

CSCI.TO : 4.45 (unch)
CSCI : 3.22 (+2.22%)
COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs

CSCI.TO : 4.45 (unch)
CSCI : 3.22 (+2.22%)
COSCIENS Biopharma Announces Change to Board of Directors

CSCI.TO : 4.45 (unch)
CSCI : 3.22 (+2.22%)

Business Summary

COSCIENS Biopharma Inc. is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. COSCIENS Biopharma Inc., formerly known as Aeterna Zentaris Inc., is based...

See More

Key Turning Points

3rd Resistance Point 3.25
2nd Resistance Point 3.23
1st Resistance Point 3.23
Last Price 3.22
1st Support Level 3.21
2nd Support Level 3.19
3rd Support Level 3.19

See More

52-Week High 11.10
Fibonacci 61.8% 7.61
Fibonacci 50% 6.53
Fibonacci 38.2% 5.45
Last Price 3.22
52-Week Low 1.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar